Other small states vs Senegal: Access to anti-retroviral drugs, female
Other small states
94.0%
in 2022
Senegal
98.0%
in 2024
Other small states rank
1st
Senegal rank
1st
Access to anti-retroviral drugs, female over time
- Other small states
- Senegal
How they compare
Senegal currently reports 98.0% against 94.0% in Other small states, a difference of 4.0%.
The two have swapped places 5 times across 20 shared years of data; in 2000 it was Other small states ahead.
Other small states ranks 1st and Senegal ranks 1st of 19 groups.
Across the 3 decades both report, Other small states averaged higher in 1 and Senegal in 2.
Head to head by decade
| Decade | Other small states | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 7.2% | 10.7% | 3.6% | Senegal |
| 2010s | 62.1% | 62.8% | 0.7% | Senegal |
| 2020s | 93.8% | 93.7% | 0.2% | Other small states |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Other small states or Senegal?
- Senegal, at 98.0% against 94.0% in Other small states as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Other small states and Senegal?
- 4.0%, with Senegal ahead.
- How many years of comparable data are there for Other small states and Senegal?
- 20 years are reported by both, from 2000 to 2022.
- How do Other small states and Senegal rank globally for access to anti-retroviral drugs, female?
- Other small states ranks 1st and Senegal ranks 1st of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.